Navigation Links
CTRC-AACR San Antonio Breast Cancer Symposium
Date:11/4/2008

The CTRC-AACR San Antonio Breast Cancer Symposium features the latest findings in laboratory, translational and clinical breast cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing breast cancer.

To help you take the best advantage of the symposium's scientific abstracts and related activities, we encourage you to visit www.sabcs.org to view the new press policies developed in partnership with the American Association for Cancer Research (AACR).

The 2008 San Antonio Breast Cancer Symposium (SABCS) will be the first Symposium presented by the CTRC (Cancer Therapy & Research Center) at the University of Texas Health Science Center at San Antonio, AACR and the Baylor College of Medicine. More than 1,000 abstracts will be presented at the symposium, complementing an outstanding program of scientific and educational events.

Highlights:

  • Practice-changing data on the role of zolendric acid in late-stage breast cancer
  • How changes in breast density can predict outcome with tamoxifen
  • Why rest is as important as physical activity in breast cancer prevention
  • Recurrence rates among patients with small HER2-positive tumors
  • Evaluation of letrozole as adjuvant endocrine therapy
  • Phase III trials of new, paradigm-shifting clinical agents like topoisomerase

When:
December 10-14, 2008

Where:
Henry B. Gonzales Convention Center
San Antonio, TX

CTRC-AACR Press Room:
Location: Room 217 A/B, Convention Center
Hours: Wed. 12:00 p.m. to 7:00 p.m.
Thurs. to Sat. 8:00 a.m. 7 p.m.
Sun. 8:00 a.m. 12:00 p.m.

E-mail: ByrdJ@uthscsa.edu

Hotel Accommodations:
Housing registration is open. Please visit: http://www.sabcs.org/Housing/Index.asp

Contact/Press Registration:
Jill Byrd
Ph: (210) 450-5550
Fax: (210) 450-1686
Byrdj@uthscsa.edu


'/>"/>

Contact: Jill Byrd
Byrdj@uthscsa.edu
210-450-5550
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. 31st Annual San Antonio Breast Cancer Symposium
2. UC Davis researchers discover a key to aggressive breast cancer
3. Study links nicotine with breast cancer growth and spread
4. SNM releases new fact sheet on breast cancer and molecular imaging
5. Study looks at psychological impact of gene test for breast cancer
6. Second lumpectomy for breast cancer reduces survival rates
7. Breast cancer cells recycle to escape death by hormonal therapy
8. The dietary supplement genistein can undermine breast cancer treatment
9. Breast cancer treatment resistance linked to signaling pathway
10. Expanding cell girth indicates seriousness of breast cancer
11. Stem cells may solve mystery of early pregnancy breast cancer protection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... and PUNE, India , January 19, 2017 ... Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the global biometric ... CAGR of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... security for both public and private sectors. Continue ... ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/11/2017)... 11, 2017 Intoxalock, a leading ignition interlock ... of its patent-pending calibration device. With this new technology, ... securely upload data logs and process repairs at service ... "Fighting drunk driving through the application of cutting-edge ... large, but also for the customer who can get ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" ... useful molecular diagnostic tests and pathology services, today ... purchase agreement with three  institutional investors to purchase ... in a registered direct offering.  In a concurrent ... to the same investors warrants to purchase 855,000 ...
(Date:1/21/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, today presented data from two clinical ... 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers ... In a Phase Ib/II study of napabucasin ... cancer stemness pathways by targeting STAT3 – colorectal cancer ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
(Date:1/19/2017)... 19, 2017 Research and Markets has announced ... Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, ... ... global market is projected to reach $15,737 million by 2022 from ... to 2022. Omic technologies segment accounted for more ...
Breaking Biology Technology: